FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1587016945> ?p ?o ?g. }

• W1587016945 endingPage "42" @default.
• W1587016945 startingPage "139" @default.
• W1587016945 abstract "Small intestinal bacterial overgrowth (SIBO) may coexist with irritable bowel syndrome (IBS) and eradication therapy has been reported as effective in reducing IBS symptoms. Aims of this study were to: (1) Assess the clinical profiles of IBS patients, who underwent breath testing with a glucose substrate--glucose breath test (GBT); (2) Evaluate hydrogen and methane parameters in various IBS groups; (3) Assess the role of inhibition of gastric acid in contributing to SIBO; (4) Investigate efficacy and safety of non-absorbable antibiotic rifamixin for eradication and symptom relief.204 IBS patients met the ROME II criteria for IBS (170F & 34M; mean age 46.4; range 18-88) and underwent GBT. 8 of these patients with positive GBT were treated with rifaximin 200 mg, 4 times a day for 1 month and symptom assessments and GBT were repeated.93 (46%) had a positive GBT. 68 (73%) of these 93 IBS-diarrhea dominant (IBS-D), 12 (13%) were constipation dominant (IBS-C) and 13 (14%) IBS with alternating bowel pattern. 48% of SIBO positive patients were receiving PPI therapy compared to 40% of IBS patients with negative GBT. 61 (66%) produced only hydrogen, 27 (29%) methane only, and 5 (5%) both-hydrogen and methane. There were more methane producers in IBS-C then IBS-D group (58% vs 28%) while IBS-D had more hydrogen formers (71% vs 42%). 8 patients with SIBO (7F & IM; mean age 55, range 31-85) received rifamixin 800 mg/day. Repeat GBT was normal in 6 (75%), 1 patient (12.5%) normalized according to hydrogen criteria but methane remained positive. Symptoms score improved in 7 (87.5%) patients and no adverse events were noted.(1) SIBO was present in nearly half of this large cohort of IBS patients based on the results of GBT; (2) Chronic PPI use was not associated with SIBO; (3) Methane formers on the GBT are more likely to be constipated; (4) Rifaximin is effective in treatment of SIBO in IBS and controlled trials are warranted." @default.
• W1587016945 created "2016-06-24" @default.
• W1587016945 creator A5055671579 @default.
• W1587016945 creator A5066495026 @default.
• W1587016945 date "2007-01-01" @default.
• W1587016945 modified "2023-10-03" @default.
• W1587016945 title "Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial." @default.
• W1587016945 cites W119395284 @default.
• W1587016945 cites W1918209772 @default.
• W1587016945 cites W1962821084 @default.
• W1587016945 cites W1972667757 @default.
• W1587016945 cites W1987400632 @default.
• W1587016945 cites W1991717338 @default.
• W1587016945 cites W1992348505 @default.
• W1587016945 cites W2007435811 @default.
• W1587016945 cites W2018028043 @default.
• W1587016945 cites W2052498454 @default.
• W1587016945 cites W2077005896 @default.
• W1587016945 cites W2078814736 @default.
• W1587016945 cites W2090190545 @default.
• W1587016945 cites W2115917215 @default.
• W1587016945 cites W2120896017 @default.
• W1587016945 cites W3152324100 @default.
• W1587016945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18217406" @default.
• W1587016945 hasPublicationYear "2007" @default.
• W1587016945 type Work @default.
• W1587016945 sameAs 1587016945 @default.
• W1587016945 citedByCount "48" @default.
• W1587016945 countsByYear W15870169452012 @default.
• W1587016945 countsByYear W15870169452013 @default.
• W1587016945 countsByYear W15870169452014 @default.
• W1587016945 countsByYear W15870169452015 @default.
• W1587016945 countsByYear W15870169452016 @default.
• W1587016945 countsByYear W15870169452017 @default.
• W1587016945 countsByYear W15870169452018 @default.
• W1587016945 countsByYear W15870169452019 @default.
• W1587016945 countsByYear W15870169452020 @default.
• W1587016945 countsByYear W15870169452021 @default.
• W1587016945 countsByYear W15870169452022 @default.
• W1587016945 countsByYear W15870169452023 @default.
• W1587016945 crossrefType "journal-article" @default.
• W1587016945 hasAuthorship W1587016945A5055671579 @default.
• W1587016945 hasAuthorship W1587016945A5066495026 @default.
• W1587016945 hasConcept C126322002 @default.
• W1587016945 hasConcept C2775981797 @default.
• W1587016945 hasConcept C2776345142 @default.
• W1587016945 hasConcept C2776409635 @default.
• W1587016945 hasConcept C2778271842 @default.
• W1587016945 hasConcept C2778889925 @default.
• W1587016945 hasConcept C2779802037 @default.
• W1587016945 hasConcept C2780999109 @default.
• W1587016945 hasConcept C2781112942 @default.
• W1587016945 hasConcept C501593827 @default.
• W1587016945 hasConcept C71924100 @default.
• W1587016945 hasConcept C86803240 @default.
• W1587016945 hasConcept C89423630 @default.
• W1587016945 hasConcept C90924648 @default.
• W1587016945 hasConceptScore W1587016945C126322002 @default.
• W1587016945 hasConceptScore W1587016945C2775981797 @default.
• W1587016945 hasConceptScore W1587016945C2776345142 @default.
• W1587016945 hasConceptScore W1587016945C2776409635 @default.
• W1587016945 hasConceptScore W1587016945C2778271842 @default.
• W1587016945 hasConceptScore W1587016945C2778889925 @default.
• W1587016945 hasConceptScore W1587016945C2779802037 @default.
• W1587016945 hasConceptScore W1587016945C2780999109 @default.
• W1587016945 hasConceptScore W1587016945C2781112942 @default.
• W1587016945 hasConceptScore W1587016945C501593827 @default.
• W1587016945 hasConceptScore W1587016945C71924100 @default.
• W1587016945 hasConceptScore W1587016945C86803240 @default.
• W1587016945 hasConceptScore W1587016945C89423630 @default.
• W1587016945 hasConceptScore W1587016945C90924648 @default.
• W1587016945 hasLocation W15870169451 @default.
• W1587016945 hasOpenAccess W1587016945 @default.
• W1587016945 hasPrimaryLocation W15870169451 @default.
• W1587016945 hasRelatedWork W1483462250 @default.
• W1587016945 hasRelatedWork W1578335338 @default.
• W1587016945 hasRelatedWork W1994240009 @default.
• W1587016945 hasRelatedWork W1995504800 @default.
• W1587016945 hasRelatedWork W2007435811 @default.
• W1587016945 hasRelatedWork W2009348105 @default.
• W1587016945 hasRelatedWork W2016005958 @default.
• W1587016945 hasRelatedWork W2024601462 @default.
• W1587016945 hasRelatedWork W2049851010 @default.
• W1587016945 hasRelatedWork W2061619758 @default.
• W1587016945 hasRelatedWork W2064201279 @default.
• W1587016945 hasRelatedWork W2077005896 @default.
• W1587016945 hasRelatedWork W2087956925 @default.
• W1587016945 hasRelatedWork W2103771013 @default.
• W1587016945 hasRelatedWork W2115895723 @default.
• W1587016945 hasRelatedWork W2120896017 @default.
• W1587016945 hasRelatedWork W2141397074 @default.
• W1587016945 hasRelatedWork W2149216059 @default.
• W1587016945 hasRelatedWork W2151028255 @default.
• W1587016945 hasRelatedWork W2430285748 @default.
• W1587016945 hasVolume "52" @default.
• W1587016945 isParatext "false" @default.
• W1587016945 isRetracted "false" @default.
• W1587016945 magId "1587016945" @default.

• next